(Q47627937)

4 February 2018

title

Clinical evaluation of p53 mutations in urothelial carcinoma by IHC and FASAY. (English)

1 reference

4 February 2018

author name string

Jun Watanabe

1

1 reference

4 February 2018

Hiroyuki Nishiyama

2

1 reference

4 February 2018

Kazutoshi Okubo

3

1 reference

4 February 2018

Takeshi Takahashi

4

1 reference

4 February 2018

Yoshinobu Toda

5

1 reference

4 February 2018

Tomonori Habuchi

6

1 reference

4 February 2018

Yoshiyuki Kakehi

7

1 reference

4 February 2018

Mitsuhiro Tada

8

1 reference

4 February 2018

Osamu Ogawa

9

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 May 2004

1 reference

4 February 2018

published in

Urology

1 reference

4 February 2018

volume

63

1 reference

4 February 2018

page(s)

989-993

1 reference

4 February 2018

issue

5

1 reference

4 February 2018

Cystectomy for bladder cancer: a contemporary series

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

The role of systemic chemotherapy in the management of muscle-invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

Noninvasive molecular detection of cancer -- the bench and the bedside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

Identification of p53 gene mutations in bladder cancers and urine samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

p53, the cellular gatekeeper for growth and division

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

Predicting response to cancer chemotherapy: the role of p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

Accumulation of nuclear p53 and tumor progression in bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

p53 mutations in urinary bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

Clonality and stability of the p53 gene in human astrocytic tumor cells: quantitative analysis of p53 gene mutations by yeast functional assay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

A simple p53 functional assay for screening cell lines, blood, and tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

Improving the detection of p53 mutations in breast cancer by use of the FASAY, a functional assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

Efficacy of dose-intensified MEC (methotrexate, epirubicin and cisplatin) chemotherapy for advanced urothelial carcinoma: a prospective randomized trial comparing MEC and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin). Japanese Urothel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

Absence of p53 overexpression and favorable response to cisplatin-based neoadjuvant chemotherapy in urothelial carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

A high easy-to-treat complication rate is the price for continent stoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

Loss of function and p53 protein stabilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

Alterations of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: high frequency of TP53 accumulation in the absence of detected mutations is associated with poor prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

Evaluation of methods to detect p53 mutations in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

Use of a yeast assay to detect functional alterations in p53 in prostate cancer: review and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

p53 and treatment of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.031

10.1016/J.UROLOGY.2003.11.031

7 January 2021

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

15135005

1 reference

4 February 2018